Interaction Between Nalbuphine and Morphine in PCA
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00155233
Recruitment Status : Unknown
Verified June 2005 by National Taiwan University Hospital. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Age 18-65 y/o
Female patients of ASA physical status I to III
Scheduled for elective abdominal hysterectomy, myomectomy, or excision of ovarian tumor
Patients with a definite diagnosis of chronic pain syndrome, psychiatric disorders, or drug abuse (include opioids, NSAIDs, sedatives, antidepressants)
Intraoperative fentanyl use > 3 μg/kg
Patients with definite diagnosis of esophageal reflux syndrome
Use of sedatives, antiemetics, or antipruritics within 24 hours before operation